Trials / Completed
CompletedNCT00252135
A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma
An Epidemiologic Study of Xolair (Omalizumab): Evaluating Clinical Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma (EXCELS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8,023 (actual)
- Sponsor
- Genentech, Inc. · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multicenter, prospective, observational cohort study of \~5000 Xolair-treated and \~2500 non-Xolair-treated patients with moderate to severe persistent asthma and a positive skin test or in vitro reactivity to an aeroallergen.
Conditions
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2005-11-11
- Last updated
- 2017-05-12
Source: ClinicalTrials.gov record NCT00252135. Inclusion in this directory is not an endorsement.